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Fig. 1. (a) Schematic description of the immunological sandwich structure of PSA formed on an electrode; (b) photo of a working electrode with a wire attached to its surface.
The  square at the center of the electrode is the window; (c) control experiments performed with immobilized primary antibody and HRP-labeled secondary antibody under
different conditions show featureless CVs of the electrode; and (d) a set of CVs obtained with a 10 ng mL−1 PSA electrode. CV1 was  obtained in PBS, showing a pair of redox
peaks indicated by the arrows. CV2–CV4 were obtained with the same electrode in different H2O2 concentrations.
[10]. In this article, we describe the ultrasensitive detection of
PSA achieved by applying FEED to the conventional ampero-
metric immunosensing scheme, in which the nanometer-sized
antibody–antigen–antibody (Ab–Ag–Ab) sandwich structure
is formed on an electrode as shown in Fig. 1(a). The intrinsic
amplification provided by FEED has allowed us to detect PSA in
serum samples with 27 fg mL−1 detection limit with 20 fg mL−1
detection resolution. Note that electron transfer through the
Ab–Ag–Ab nanostructure in immuno-sensing systems is an over-
looked problem, although amperometric signals (electric currents)
traveling through the Ab–Ag–Ab structure has been observed in
the detection of biomarkers. Our results indicate the feasibility of
using FEED to control electron transfer through the nanostructure,
leading to an ultralow detection limit for PSA. The electrochemical
nature of the detection and the ultralow detection of PSA in serum
suggest the possibility of integration of the detection system with
microfluidics on chips, leading to the point-of-care approach for
early detection of recurrence of prostate cancer after prostatectomy
[11].
2. Experimental
2.1. FEED system
The  principle of FEED has been explained and the detection
system described previously [10]. Briefly, the detection system
consists of a conventional three-electrode electrochemical cell
modified with additional gating electrodes for applying a gating
voltage VG to the detecting (working) electrode, on which a redox
enzyme, the sensing element, is immobilized. VG rearranges ions
in the sample solution at the electrode–solution interface, inducing
an electric field that penetrates the immobilized enzyme. The field
reduces the effective height of the tunnel barrier between the active
site of the enzyme and the electrode, therefore increasing the tun-
nel rate of electrons and resulting in intrinsic amplification of the
signal current. A detailed description of the FEED-immunosensing
system used in this work is provided in the Appendix (Supplemen-
tary Material). In the present application of FEED, the enzyme is
immobilized on the electrode via the sandwich immune complex.
        
2.2. Reagents, electrodes and measurements
PSA samples and antibodies used in this work were purchased
from ANOGEN (Mississauga, Canada). Monoclonal (mouse) anti-
human PSA antibody (clone number CHYH1) was  used as the
primary antibody, and polyclonal anti-human PSA antibody (clone
number CHYH2) labeled with horseradish peroxidase (HRP) was
used as the secondary antibody. PSA standard solutions in calf
serum and the control sample (serum without PSA) were used in
detection and control measurements. Disks of pyrolytic graphite
(PG) (3 cm × 3 cm)  were used as electrodes. A layer of the conduct-
ing polymer, polyaniline (PANI), was deposited on PG electrodes to
host antibodies on electrodes [12] and to be used as electron medi-
ator, shuttling electrons between HRP and the electrode [13]. The
PANI layer was synthesized on the electrode using electrochemical
polymerization of aniline in a solution of 0.1 M aniline and 1 M HCl
at a potential of 1.2 V for 100 s [14]. The PANI prepared using this
method was used previously in a HRP-based biosensor to detect
H2O2 at pH 6.8 [15] as well as in a pH sensor [16] because the
conductivity of PANI persists up to pH 9. Alternatively, sulfonated
PANI was prepared by adding poly(vinylsulfonic acid) (Aldrich, cat.
# 27,842-4) to aniline and HCl during electrochemical polymer-
ization as described previously [17], to increase the redox activity
of PANI at pH 7. The results shown in this work were obtained
with PANI prepared using HCl only while the two  kinds of PANI
led to similar results. Glutaraldehyde was used as a cross-linker,
coupling the primary antibody to the highly porous PANI so that
the Ab–PSA–Ab(HRP) structure was firmly entrapped in PANI and
the HRP was in contact to PANI. Previous XPS analysis [12] shows
that glutaraldehyde binds to the amine groups on PANI to form an
imine bond.
A  plastic mask with a 2 mm × 2 mm to 3 mm  × 3 mm opening
was used to define a window on the PANI layer. The window
was further modified by depositing 2 L of glutaraldehyde (25%
with water, diluted 100 times with water) on PANI until dry. PSA-
detecting electrodes were formed by incubating the modified PG
electrodes with 10 L of 1 mg/mL  primary antibody dissolved in
phosphate buffered saline (PBS) for 1 h at room temperature and
a subsequent rinse with de-ionized water. To detect PSA, a PSA-
detecting electrode was incubated with 5–10 L of a PSA sample
(a PSA standard serum solution) for 1 h at 37 ◦C. After rinsing with
de-ionized water and blocking possible open areas on the electrode
with bovine serum albumin (40 mg/mL  diluted to 10% in Dulbecco’s
phosphate-buffered saline), the same electrode was  incubated with
5–10 L of 0.5 g/mL HRP-labeled secondary antibody for 30 min  at
37 ◦C and then rinsed with de-ionized water. The Ab–PSA–Ab(HRP)
sandwich structure now has formed on the electrode. Finally, the
electrode was now formed as the working electrode for electro-
chemical measurements. A piece of 0.5 mm-diameter copper wire
coated with a thin layer of insulator (enamel) was used as the gating
electrode for applying VG. The wire was bent to form a U-shaped
structure and was attached on the sensing electrode using non-
conductive epoxy. Fig. 1(b) shows a working electrode with a wire
attached to its surface. All PSA samples were prepared with undi-
luted serum sample as received. Note that, for each data point on
the calibration curves shown in this work, 5 electrodes were made
and tested for proper behaviors. Generally, 3 or 4 electrodes showed
the proper behaviors such as the presence the redox peaks of the
enzyme and were used to determine the data point.
Electrochemical measurements made using a conventional
three-electrode electrochemical cell were used to extract the detec-
tion signal. A commercial Ag/AgCl (3 M KCl) electrode was used
as the reference electrode, and a platinum wire was used as the
counter electrode. The volume of the electrochemical cell was
1 mL.  The cell was driven by a commercial electrochemical con-
troller (CHI 660C Work Station). A potential scan rate of 20 mV/s
was  used in recording cyclic voltammograms (CV) and linear
voltammograms (LV). PBS (0.1 M at pH 7) was prepared using
de-ionized water (18.2 M cm). Commercially available hydro-
gen peroxide (Fisher scientific, 30% concentration) was diluted
to the concentrations used in the experiment. All measurements
were made with deaerated PBS at room temperature. Reproducible
results were obtained by repeating each measurement multiple
times.
3. Results and discussion
The  detection of PSA was achieved by applying FEED to the con-
ventional amperometric immuno-sensing method, the operation
of which requires the sandwich structure, Ab–PSA–Ab(HRP), to be
formed on the PSA-detecting electrode as shown in Fig. 1(a). Control
experiments were performed using electrodes immobilized with
different participants of the immuno-reaction in order to avoid mis-
interpretation of experimental results. Fig. 1(c) shows a set of cyclic
voltammograms (CVs) obtained under different conditions with a
PG electrode modified with PANI and glutaraldehyde as described
above. The modified electrode was first immobilized with the pri-
mary Ab and subsequently with the labeled secondary Ab(HRP)
followed by a rinse to remove unstable structures from the elec-
trodes. CV1 and CV2 were obtained respectively with this electrode
in PBS only and PBS with the presence of 0.3 mM H2O2. Note that
H2O2 is reduced to water by the catalytic activity of HRP [18]. CV3
was obtained with the same electrode in H2O2 when a VG of 0.3 V
was applied. The three CVs appear to be featureless and have similar
magnitudes. Similar results were obtained with the modified elec-
trode, which was  immobilized first with PSA and subsequently with
secondary Ab(HRP) to form the PSA–Ab(HRP) immuno-complex.
Additional control experiments using graphite electrodes without
PANI but with glutaraldehyde and the sandwich immuno-complex
resulted in no observable signal.
Fig. 1(d) shows a set of CVs obtained with a modified electrode,
which was  further processed according to the procedures required
to form the Ab–PSA–Ab(HRP) structure as described above. The
concentration of PSA used to prepare this electrode was  10 ng mL−1.
CV1 was obtained in PBS, showing a pair of redox peaks as indicated
by the arrows with a formal potential of −0.3 V vs. Ag/AgCl. Previous
works on the direct electron transfer associated with immobilized
HRP show that the formal potential of this redox process is between
−0.5 V and −0.3 V vs. Ag/AgCl [19,20]. Thus, the redox peaks in
CV1 indicate the formation of Ab–PSA–Ab(HRP) immuno-complex,
which supports the transfer of electrons between the HRP and
the electrode as observed in immuno-sensors. Alternatively, for-
mation of Ab–PSA–Ab(HRP) immuno-complex was confirmed by
testing the enzymatic activity of HRP using this electrode. CVs 2–4
in Fig. 1(d) were obtained with different concentrations of H2O2
in the cell. The electrode responded to the increasing H2O2 con-
centration by progressively increasing the cathodic current due to
the reduction of H2O2 catalyzed by HRP. Note that although the CVs
show weak and broadened redox peaks, the fact that the electrode’s
cathodic current responds to H2O2 indicates the enzymatic activity
of HRP as previously observed [21].
In this work, two  approaches were used to obtain the detec-
tion signal. The first approach required the measurement of the
reduction peak current of HRP and used it as the signal. This is
a reagentless method [22], in which no H2O2 is used to initiate
the activity of HRP. To carry out the detection, cyclic voltam-
metry or linear voltammetry (LV) was  performed with electrodes,
on which the Ab–PSA–Ab(HRP) structure was  formed with serum
solutions containing different PSA concentrations. Specifically, the
detection signal was obtained by measuring the reduction currents
of the Ab–PSA–Ab(HRP) electrodes at about −0.32 V vs. Ag/AgCl,
Fig. 2. (a) LVs of 2 detecting electrodes, which have been incubated with 1 and 10 ng mL−1 of PSA, obtained in the absence of VG. The LVs indicate the increase in the reduction
peak current of HRP as the PSA concentration is increased; (b) the PSA calibration curve of the detection system in the absence of VG; (c) PSA calibration curve in the fg mL−1
range obtained with VG = 0. The red line is the regression line; (d) four CVs obtained using a 50 fg mL−1 PSA detecting electrode with increasing values of VG. The reduction
peak current increases as VG is increased from 0 V to 0.3 V, indicating the intrinsic amplification; and (e) PSA calibration curve in the fg mL−1 range obtained with VG = 0.3 V.
The  red line is the regression line. (For interpretation of the references to color in this figure legend, the reader is referred to the web  version of the article.)
where the reduction peak is located. Fig. 2(a) shows the LVs of two
Ab–PSA–Ab(HRP) electrodes, which were incubated with different
PSA concentrations (1 and 10 ng mL−1), obtained in the absence
of VG. The LVs show that as the PSA concentration is increased,
the reduction peak current increases. Fig. 2(b) shows the PSA cali-
bration curve of the detection system obtained in the absence of
VG. The data points indicate a detection range of 0.001 ng mL−1
(1000 fg mL−1)–40 ng mL−1 of PSA. The curve shows two linear
regions.  The high-concentration portion of the curve, i.e. the range
1–40 ng mL−1, exhibits a linear dependence of the signal current on
PSA concentration and covers the prostate cancer screening range
[23]. Below 1000 fg mL−1, however, the detection appears to be
unsatisfactory. The calibration curve in Fig. 2(c) shows the detailed
structure of the curve below 1000 fg mL−1. The first four data points
(30, 50, 70, 100 fg mL−1) indicate extremely low currents and their
values overlap. At higher concentrations (300, 500, 1000 fg mL−1) a
linear region appears. The red line is the regression line for the data
points, having a correlation coefficient of 0.98756. The sensitivity is
2.3 × 10−2 nA mL/fg. The detection limit of this PSA concentration
range was estimated to be 119 fg mL−1, using the signal/noise = 3
method. The small error bars indicate reproducible device perfor-
mance.
Electron transfer in amperometric immuno-sensing systems
is an overlooked problem. The length of the non-electroactive
Ab–Ag–Ab nanostructure is on the order of ∼20 nm for protein
biomarkers. Since electron tunnel rate depends exponentially on
distance as ket ∝ exp(−ˇd), where d is the distance through the
insulating barrier between the donor and the acceptor and  ˇ is the
attenuation coefficient, which is proportional to the square root
of the tunnel barrier height (  ˇ ∝ (Фo)1/2) [24], the length of the
nanostructure is long enough to diminish the electron transfer rate
and, therefore, reduce detection sensitivity. The FEED technique
modifies the energy profile of the Ab–Ag–Ab nanostructure so that
Фo is reduced and hence the electron transfer rate through this
nanoscale interfacial region is enhanced, resulting in signal ampli-
fication and significantly lowered detection limit. This mechanism
has been studied in several publications [10,25,26]. In particular,
the effect of VG on the reduction-peak current has been previ-
ously observed to increase as VG was increased [26]. Further, the
same principle has been used to control electron flow in non-
electroactive protein and nanotubes [27,28]. Fig. 2(d) shows four
CVs obtained using a 50 fg mL−1 PSA electrode with different val-
ues of VG. Fig. 2(d) shows that the reduction-peak current increases
from zero to 3 nA as VG is increased from 0 V to 0.3 V, indicating
the voltage-controlled (intrinsic) amplification. The reduction peak
current will keep increasing of greater VG values. Previously, the
increase in the signal current of the FEED system, which is used in
this work, caused by VG in the positive polarity was  attributed to
the reduction of the height of the tunnel barrier between the active
site of the enzyme and the electrode. VG induces an electric field at
the enzyme–electrode interface, and the field reduces the effective
height of the tunnel barrier, resulting in an increase in the tunnel
rate of electrons [10,25,26]. It is believed that the same mecha-
nism is responsible for the observed increase in the signal current
in the present work. A confirmation of this mechanism is provided
by reversing the polarity of VG as shown previously [25,26]. The
reduction peak current decreases as VG becomes negative because
the tunnel barrier becomes higher.
The calibration curve in Fig. 2(e) is the PSA calibration curve
in the fg mL−1 range obtained with VG = 0.3 V, which was  chosen
for this concentration range. The first data point, 30 fg mL−1, indi-
cates an extremely low current. Beyond that, each data point is
clearly separated from others, indicating detection with fg mL−1
resolution. The first four data points indicate a linear dependence
of signal on PSA concentration. Higher concentration data points
show a deviation from the linearity possibly due to less available
binding sites or crowding. The red line is the regression line for the
first four data points, having a correlation coefficient of 0.99200.
The sensitivity derived using the red line is 0.118 nA mL/fg. The
detection limit estimated using this PSA concentration range is
27 fg mL−1, using the signal/noise = 3 method. The small error bars
indicate reproducible device performance. Fig. 2(c) and (e) shows
that the application of VG has increased the detection sensitivity
while lowered the detection limit.
Detection of PSA was also achieved by monitoring the temporal
responses of electrodes, on which the Ab–PSA–Ab(HRP) struc-
ture was formed, when H2O2 was injected into the cell with VG
set to a constant value. Fig. 3(a) shows temporal traces obtained
with different electrodes with the cell potential set at −0.32 V and
VG = 0.3 V. The initial jump in the current was caused by injecting
0.1 mM H2O2 at the electrodes. The control trace, obtained with
only the primary Ab and the labeled secondary Ab(HRP) on the
Fig. 3. (a) Temporal traces obtained with different PSA-detecting electrodes with
the cell potential set at −0.32 V and VG = 0.3 V. The initial jumps in the current were
caused  by injecting 0.1 mM H2O2 near the electrodes; (b) the PSA calibration curve
on  the fg mL−1 level based on the temporal measurements. The red line is the regres-
sion  line. (For interpretation of the references to color in this figure legend, the reader
is referred to the web  version of the article.)
electrode, is also displayed in Fig. 3(a). The plateau of each trace
was used as the detection signal since the peak current was  caused
by injecting H2O2 near the electrodes surface. Fig. 3(b) shows the
PSA calibration curve on the fg mL−1 level. The first four data points
indicate a linear dependence of signal on PSA concentration. Higher
concentration data points show a deviation from the linearity pos-
sibly due to less available binding sites or crowding. The red line is
the regression line for the first four data points, having a correlation
coefficient of 0.99100. The sensitivity derived using the red line is
3.50 nA mL/fg. The detection limit of this PSA concentration range
was estimated to be 39 fg mL−1, using the signal/noise = 3 method.
The small error bars indicate reproducible device performance.
Comparing Fig. 3(b) and Fig. 2 (e) shows two  characteristics of
the two  methods for getting the detection signal. The use of H2O2
has significantly increased the signal current level, which might be
the cause for the improved linear dependence of the signal on PSA
concentration as shown in Fig. 3(b). Further, Fig. 3(b) also shows
that the use of H2O2 has significantly enhanced detection sensi-
tivity. However, since the noise fluctuation (zero PSA current) has
also become larger due to the use of H2O2 and the amplification
provided by the detection system, the detection limit of the H2O2-
based amperometric method has become higher than that of the
reagentless method for the same value of VG. Nevertheless, the
enhanced sensitivity was  able to keep the detection limit below
100 fg mL−1.
The ultrasensitive detection of PSA provided by the FEED-based
detection method has been demonstrated using two  approaches to
obtain the detection signal, showing similar detection limits on the
fg mL−1 level. This capability is due to the intrinsic amplification
of FEED and is illustrated using Fig. 2(c) and (e). The two  calibra-
tion curves in these figures involve the same PSA concentrations.
The curve in Fig. 2(c), obtained with VG = 0 V, shows a smaller cur-
rent span and the four lowest concentrations yield zero current.
The effect of VG is reflected in the curve in Fig. 2(e), where each of
the four lowest concentrations corresponds to a distinctive current
with small error bars. The curve also shows a detection resolu-
tion of 20 fg mL−1 and a larger current span. The selectivity of the
detection method has been demonstrated by the fact that all PSA
samples used in this work, including those used in the fg mL−1 level
detection, were prepared with undiluted serum sample as received.
Generally, serum contains a large number of biological substances
such as proteins, hormones, enzymes, and antibodies. The fact that
PSA detection has been successful on the fg mL−1 level, where PSA
samples have been diluted 1-million times using undiluted serum
sample or other biological substances have a 1-million-fold higher
concentration, indicates high detection selectivity. Another impor-
tant property of the detection system is the limited detection of
PSA below 1000 fg mL−1 obtained without VG. We  attribute this
low concentration detection capability to the immobilization of
the primary antibody and hence the Ab–PSA–Ab(HRP) structure in
PANI. The redox activity of PANI is known to lead to high detection
sensitivity [29]. When the primary antibody is entrapped in the
PANI matrix, PANI serves as an efficient non-diffusional electron
mediator [15].
The  ultrasensitive PSA detection technique reported here
exhibits several advantages compared with the two  published
ultrasensitive PSA detection methods described above [8,9]. The
PSA detection limits of 27 fg mL−1 and 39 fg mL−1 demonstrated
in the present work are noticeably lower than those obtained
in the two published works. The FEED-based technique with its
intrinsic amplification basically requires no additional processing
of reagents other than that is required to form the sandwich struc-
ture while the other two methods require extensive preparation
of reagents to achieve signal amplification. Also, the FEED-
based technique employs an interfacial electric field to enhance
the transfer of electrons so that no electron transfer media-
tors are needed in the operation of the detection system. Thus,
the featured detection technique appears to be a more attrac-
tive approach for applications that demand fast detection and
low-cost.
4. Conclusions
This work shows that FEED, when combined with the conven-
tional amperometric immuno-sensing, can be used to detect PSA
in serum with detection limit on the fg mL−1 level. This capabil-
ity has been demonstrated using two approaches in obtaining the
detection signal, resulting in detection limit as low as 27 fg mL−1.
The high selectivity of the detection system is provided by the
immunological reaction and is reflected in the fact that PSA detec-
tion has been successful with PSA samples that contained other
biological substances having a 1-million-fold higher concentration.
Note that the FEED-based immuno-sensing technique is a media-
torless approach, while most electrochemical immuno-sensors use
mediators, which may  lead to the leaching of the mediators out
of the electrode, resulting in significant signal loss. The ultrasen-
sitive detection and the electrochemical nature of the detection
technique suggest the detection system can be integrated with
microfluidics on chips for ultrasensitive analysis of small volume
or  low-concentration PSA samples for early detection of recurrence
of prostate cancer.
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